Subtype
Gestational Trophoblastic Tumor
CI-CAN-00000928GTTExplore in graph →
Non-malignant8 active trials
Loading cancer entity…
Subtype
CI-CAN-00000928GTTExplore in graph →
Clinical trials
61 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06790706 | IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers(IMMUNORARE5) | active not recruiting | Phase 2 | 27 | Hospices Civils de LyonOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH |
| 2 |
| Jun 17, 2026 |
| clinicaltrials |
| NCT01008501 | Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles | active not recruiting | — | 100 | Baylor College of MedicineOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT04562558 | Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | active not recruiting | N/A | 228 | xiang yangOTHER | 1 | Aug 11, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Jun 25, 2026source: clinicaltrials